Digest Network Come funziona
Network
/
Società
Or
Non verificato

Orca Bio

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaOncologiaSalute

21 comunicati stampa

Guarda tutti i comunicati
18/05/2026
Mercato del lavoro
Oncologia
Salute
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
28/04/2026
Industria
Oncologia
Igiene alimentare
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
01/04/2026
Industria
Biotecnologia
Farmaceutica
Salute
Oncologia
Orca Bio Announces FDA Review Extension of BLA for Orca-T for the Treatment of Hematologic Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
02/03/2026
Eventi
Industria
Oncologia
Salute
Biotecnologia
Sanità
Medicina - Varie
Farmaceutica
Orca Bio to Present Clinical Data on Its Pipeline of High-Precision Cell Therapies at the 52nd Annual Meeting of the EBMT
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
05/02/2026
Biotecnologia
Farmaceutica
Salute
Oncologia
Industria
Orca Bio Presents New Data at the 2026 Tandem Meetings of ASTCT® and CIBMTR® Reinforcing Orca-T® as a Durable, High-Precision Cell Therapy for Hematological Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
21/01/2026
Scienza
Biologia
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Eventi
Industria
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
09/01/2026
Oncologia
Salute
Biologia
Sanità
Farmaceutica
Biotecnologia
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
05/01/2026
Eventi
Web e Social Network
Salute
Biologia
Farmaceutica
Oncologia
Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
15/12/2025
Industria
Oncologia
Salute
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies
Fonte
Orca Bio
Emittente
Business Wire
1.00
0
08/12/2025
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting
Fonte
Orca Bio
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0